Lower limb bypass

10 min read Last updated April 8, 2026

Surgical approach

  • Indications: critical limb-threatening ischaemia (rest pain, tissue loss), severe lifestyle-limiting claudication, acute-on-chronic ischaemia (selected cases)
    • Common operations: femoral–popliteal bypass (above/below knee), femoral–distal (tibial/pedal) bypass, aorto-bifemoral bypass, femoro-femoral crossover, axillo-femoral bypass
  • Conduit choice: autologous vein (long saphenous) preferred for distal targets; prosthetic graft (PTFE/Dacron) often for above-knee fem-pop or extra-anatomical
    • Vein harvest may be open or endoscopic; adds time and additional wound/pain sites
  • Exposure and anastomoses
    • Proximal control at common femoral artery (groin incision); distal target at popliteal/tibial/pedal artery (knee/calf/ankle/foot incisions)
    • Systemic heparinisation before clamping; arteriotomy and end-to-side anastomoses; clamp release and haemostasis
    • Completion assessment: Doppler signals, flow probe, completion angiography (variable)
  • Aorto-iliac reconstructions (if performed): midline laparotomy/retroperitoneal approach for aorto-bifemoral; higher physiological stress and blood loss than infra-inguinal bypass
    • Extra-anatomical (axillo-femoral/fem-fem): used in hostile abdomen/high risk; often less invasive but still significant comorbidity burden

Anaesthetic management

  • Type of anaesthesia: GA or regional (neuraxial/PNB) depending on level of bypass, anticoagulation plan, patient factors and local expertise
    • Infra-inguinal bypass: GA common; alternatives include CSE/spinal (if anticoagulation timing allows) or combined GA + peripheral blocks for analgesia
    • Aorto-bifemoral: GA with ETT almost always
  • Airway: ETT usually preferred (length, physiological swings, need for controlled ventilation, potential major haemorrhage); SGA only in carefully selected short, stable infra-inguinal cases
    • Consider aspiration risk (opioids, diabetes gastroparesis, bowel obstruction unlikely but aorto surgery/laparotomy increases risk)
  • Duration: fem-pop 2–4 h; fem-distal 3–6 h; aorto-bifemoral 3–6+ h; add time for vein harvest and difficult distal targets
    • Plan for prolonged immobility/pressure area care and temperature management
  • How painful: moderate–severe (multiple incisions, groin + distal + vein harvest); aorto-bifemoral severe (laparotomy + groins)
    • Analgesia strategy: multimodal + regional where safe; consider catheter techniques for prolonged analgesia
  • Monitoring and access: 2 large-bore IV; arterial line (common); consider central access if major blood loss/vasoactive infusions anticipated; urinary catheter for longer cases
    • Temperature monitoring and active warming; frequent glucose checks in diabetics
  • Key intra-op priorities: maintain perfusion pressure, avoid tachycardia/ischaemia, manage anticoagulation (heparin/protamine), anticipate blood loss, preserve graft flow (avoid severe hypotension/vasospasm)
    • Vasoactive support: noradrenaline commonly used to maintain MAP without excessive tachycardia; treat hypovolaemia first

Patient profile and comorbidity

  • Peripheral arterial disease is a marker of systemic atherosclerosis
    • High prevalence of IHD, heart failure, cerebrovascular disease, CKD, diabetes, COPD, smoking, frailty and malnutrition
  • Medication issues
    • Antiplatelets: aspirin usually continued; clopidogrel often continued for vascular indications but impacts neuraxial decisions
    • Anticoagulants: DOAC/warfarin management per local policy; bridging occasionally; impacts regional techniques
    • Statins and beta-blockers: continue; avoid initiating high-dose beta-blocker immediately pre-op unless strong indication and time for titration
  • Functional status and limb status
    • Rest pain/opioid tolerance; infected ulcers/osteomyelitis; sepsis risk; anaemia of chronic disease

Preoperative assessment and optimisation

  • Cardiovascular risk assessment
    • Identify active cardiac conditions (unstable angina, decompensated HF, significant arrhythmia, severe valvular disease) and optimise/seek cardiology input if time allows
    • Baseline ECG; echo if murmur/HF symptoms/poor functional capacity with suspected structural disease
  • Baseline bloods and transfusion planning
    • FBC (anaemia common), U&E (CKD), coagulation (anticoagulants), group & save/crossmatch depending on procedure (higher for aorto-bifemoral)
  • Infection and sepsis
    • Ulcer infection/osteomyelitis: antibiotics, lactate, cultures; consider source control timing; higher vasopressor requirement risk
  • Renal protection
    • Avoid dehydration; rationalise nephrotoxins; anticipate contrast exposure (pre-op imaging/intra-op angiography)
  • Consent and planning for postoperative destination
    • HDU/ICU for aorto-bifemoral, significant comorbidity, sepsis, major blood loss risk, or need for vasoactive support

Intraoperative anaesthetic technique

  • General anaesthesia
    • Induction: avoid hypotension/tachycardia; consider etomidate/ketamine in severe LV dysfunction or sepsis; opioid and vasopressor boluses as needed
    • Maintenance: volatile or TIVA; aim normocapnia, normothermia; avoid excessive vasodilation that jeopardises graft flow
  • Regional/neuraxial options (when appropriate)
    • Spinal/CSE: can provide stable anaesthesia for infra-inguinal surgery but sympathetic block may cause hypotension; must align with antiplatelet/anticoagulant status and intra-op heparin timing
    • Peripheral blocks for analgesia: fascia iliaca/femoral + sciatic (popliteal) ± obturator; adductor canal + sciatic may reduce quadriceps weakness; consider wound sites (groin + distal + harvest)
    • Continuous catheters (fascia iliaca/adductor canal/popliteal sciatic) can reduce opioids; balance against anticoagulation and compartment syndrome masking concerns
  • Anticoagulation and haemostasis
    • Systemic heparin typically 50–100 IU/kg before clamping (local practice varies); check ACT if used; communicate timing for neuraxial catheter removal
    • Protamine reversal may be partial/complete depending on bleeding vs thrombosis risk; watch for hypotension, pulmonary hypertension, anaphylactoid reactions (higher risk with prior exposure, NPH insulin, fish allergy)
  • Haemodynamic targets
    • Maintain coronary perfusion and graft flow: avoid sustained hypotension; common target MAP ≥ 65–75 mmHg, higher if chronic hypertension/critical limb perfusion concerns (individualise)
    • Treat causes: bleeding/hypovolaemia, vasodilation, myocardial ischaemia, arrhythmia; use noradrenaline early if vasoplegia with adequate volume
  • Fluids and blood
    • Balance: avoid hypovolaemia (graft thrombosis, AKI) and overload (cardiac failure, pulmonary oedema)
    • Blood loss: variable; can be significant with redo groins, aorto surgery, difficult dissection; have blood available as planned
  • Tourniquet: not typically used for bypass; if used for adjunct procedures, manage tourniquet physiology and analgesia

Analgesia

  • Multimodal baseline
    • Paracetamol; NSAID/COX-2 if renal function and bleeding risk acceptable; consider gabapentinoids cautiously (sedation/falls) and avoid routine use in frail elderly
  • Opioids
    • Often opioid-tolerant due to rest pain; plan PCA (morphine/oxycodone) with antiemetic and bowel regimen; consider ketamine infusion for opioid-sparing in tolerant patients
  • Regional analgesia options
    • Adductor canal + sciatic (popliteal) for below-knee targets; fascia iliaca/femoral for groin/upper thigh; local infiltration by surgeon at incisions
    • Epidural: may be used for aorto-bifemoral in some centres (excellent analgesia) but requires meticulous anticoagulation coordination and haemodynamic management

Postoperative care

  • Graft surveillance and limb assessment
    • Regular neurovascular observations: pain, pallor, pulselessness, paraesthesia, paralysis, temperature; Doppler signals; escalating analgesic requirement can be a sign of ischaemia/compartment syndrome
  • Haemodynamic and respiratory care
    • Maintain MAP to support graft and renal perfusion; manage fluids/diuresis; treat myocardial ischaemia early
  • Antithrombotic therapy
    • Post-op antiplatelet/anticoagulation per surgeon/vascular protocol; coordinate with any neuraxial/PNB catheters and removal timing
  • Complications to anticipate
    • Cardiac: MI, arrhythmia, heart failure; Renal: AKI; Respiratory: atelectasis/pneumonia; Wound: infection/lymph leak; Graft: thrombosis/bleeding
You are asked to anaesthetise a 72-year-old with diabetes, CKD3 and IHD for femoro-popliteal bypass. What are your key preoperative concerns and how will you optimise them?

Structure: comorbidities → investigations → optimisation → planning level of care.

  • Cardiac risk: PAD implies high IHD burden; assess symptoms (angina, dyspnoea), functional capacity, prior stents/CABG, heart failure history
    • Investigations: ECG; troponin only if symptomatic/concern; echo if murmur/HF symptoms; consider peri-op BNP/NT-proBNP if used locally for risk stratification
  • Renal: baseline creatinine/eGFR, electrolytes; avoid dehydration; review nephrotoxins; anticipate contrast exposure
  • Diabetes: glucose control plan; adjust insulin/oral agents; consider gastroparesis/aspiration risk; infection risk
  • Anaemia/infection: check FBC, CRP if infected ulcers; treat sepsis; crossmatch as appropriate
  • Medication optimisation: continue statin, beta-blocker (if established), aspirin; clarify clopidogrel/DOAC/warfarin plan; document last doses
  • Plan postoperative destination: consider HDU if significant IHD/HF/CKD, sepsis, anticipated vasoactive support or major blood loss
Discuss your choice of anaesthetic technique for infra-inguinal bypass. Compare GA vs neuraxial vs peripheral nerve blocks.

Examiners expect: patient/surgery factors, anticoagulation constraints, haemodynamic effects, analgesia quality, practicalities.

  • GA: reliable for long cases and multiple incisions; easier control of ventilation/CO2/temperature; facilitates urgent conversion/bleeding control
    • Risks: hypotension from induction/volatile; myocardial ischaemia; higher opioid requirement if no regional
  • Neuraxial (spinal/CSE/epidural): excellent anaesthesia/analgesia; may reduce stress response; but sympathetic block can cause hypotension jeopardising coronary and limb perfusion
    • Major limitation: antiplatelets/anticoagulants and intra-op heparinisation; must comply with local/ASRA/RA-UK guidance and timing for catheter removal
  • Peripheral nerve blocks: useful adjunct for analgesia (adductor canal/femoral + sciatic); less sympathectomy than neuraxial; can reduce opioids and facilitate early mobilisation
    • Cautions: motor weakness (falls), local anaesthetic systemic toxicity risk (large volumes), anticoagulation considerations for deep blocks, and potential to obscure evolving compartment syndrome (clinical vigilance required)
  • Pragmatic approach: GA + targeted PNB/local infiltration is common; neuraxial reserved for selected patients with acceptable coagulation status and robust haemodynamic plan
What monitoring and vascular access would you use for femoro-distal bypass and why?

Tailor to comorbidity, expected blood loss, and need for tight BP control.

  • Standard monitoring + temperature; capnography if sedated/GA
  • Arterial line: beat-to-beat BP for graft perfusion targets, rapid detection of bleeding, frequent ABGs/glucose/electrolytes
  • IV access: two wide-bore cannulae; consider rapid infuser availability if redo/bleeding risk
  • Central venous access: not routine; consider if poor peripheral access, need for vasoactive infusions, severe cardiac disease, or major surgery (aorto-bifemoral)
  • Urinary catheter: long cases, CKD, expected fluid shifts, aorto surgery
How do you manage intraoperative hypotension during lower limb bypass?

Aim: restore perfusion pressure without provoking tachycardia/ischaemia; treat cause not just numbers.

  • Immediate actions: check surgical field for bleeding, confirm BP reading (arterial line damping), assess depth of anaesthesia, ECG for ischaemia/arrhythmia
  • Volume status: give fluid bolus if hypovolaemia likely; send Hb/ABG; transfuse if significant blood loss/anaemia with ischaemia risk
  • Vasopressors: metaraminol/phenylephrine boluses for transient vasodilation; noradrenaline infusion for persistent vasoplegia (common in sepsis/volatile anaesthesia)
    • Avoid excessive pure alpha vasoconstriction if concern about peripheral vasospasm; prioritise adequate MAP and cardiac output
  • Inotropes: consider if low cardiac output (echo/clinical) e.g. dobutamine; treat myocardial ischaemia (oxygenation, analgesia, BP, rate control, GTN if hypertensive/ischaemic)
Explain the perioperative management of heparin and protamine for bypass surgery. What complications can occur?

Focus: timing, monitoring, and adverse effects.

  • Heparin: given before arterial clamping/anastomosis; dose often 50–100 IU/kg; may monitor ACT depending on centre/procedure complexity
  • Protamine: used to reverse heparin partially or fully if bleeding risk; dose guided by heparin dose/time/ACT
  • Protamine adverse effects: hypotension (rapid administration), anaphylactoid reactions, pulmonary hypertension/right heart failure, bradycardia
    • Higher risk groups: previous protamine exposure, NPH insulin use, vasectomy, fish allergy (association described; assess history pragmatically)
  • Thrombosis vs bleeding: over-reversal may increase graft thrombosis risk; under-reversal may increase bleeding/haematoma risk
A patient becomes increasingly acidotic and hyperkalaemic near the end of a prolonged femoro-distal bypass. What are the likely causes and your management?

Think: transfusion, renal impairment, tissue ischaemia/reperfusion, sepsis, hypoventilation.

  • Causes: AKI/CKD with reduced K excretion; transfusion-related hyperkalaemia (older blood, rapid transfusion); metabolic acidosis from hypoperfusion/sepsis; reperfusion of ischaemic limb; hypoventilation causing respiratory acidosis
  • Assess: ABG (pH, K, lactate), ECG changes, urine output, haemodynamics, temperature, transfusion history
  • Treat hyperkalaemia: calcium chloride/gluconate if ECG changes; insulin-dextrose; nebulised salbutamol; consider sodium bicarbonate if severe acidaemia; optimise ventilation and perfusion
  • Definitive: stop K sources, consider furosemide if appropriate, renal replacement therapy if refractory/severe with renal failure; involve ICU early
Postoperatively the patient has severe calf pain, pain on passive stretch and tense swelling after tibial bypass. What is the diagnosis and immediate management?

This is a limb-threatening emergency.

  • Diagnosis: acute compartment syndrome (may occur after revascularisation/reperfusion; can coexist with graft occlusion)
  • Immediate actions: urgent surgical review; do not delay for imaging; remove constrictive dressings; keep limb at heart level (not elevated excessively); optimise perfusion pressure and oxygenation
  • Analgesia: treat pain but avoid masking progression; regional techniques can complicate assessment—ensure heightened surveillance if blocks/catheters used
  • Definitive management: urgent fasciotomy
How would you manage antiplatelet therapy in a patient listed for lower limb bypass, and how does this affect neuraxial anaesthesia?

Answer should reference balancing thrombosis risk vs neuraxial haematoma risk and following local/national guidance.

  • Aspirin: commonly continued for vascular surgery; generally compatible with neuraxial techniques as sole agent (per guidance)
  • Clopidogrel/prasugrel/ticagrelor: often continued for vascular indications but typically contraindicate neuraxial block unless stopped for an appropriate interval and platelet function recovered (follow local/RA-UK/ASRA guidance)
  • Intra-op heparinisation: neuraxial catheter placement/removal must be timed around heparin dosing; avoid traumatic insertion; document timing meticulously
  • If neuraxial not feasible: choose GA with peripheral blocks/local infiltration for analgesia; consider superficial blocks with safer bleeding profile where appropriate
Describe the causes, recognition and management of perioperative myocardial infarction in a patient undergoing lower limb bypass.

FRCA themes: demand ischaemia, silent MI, haemodynamic management, postoperative monitoring.

  • Causes: supply-demand mismatch (anaemia, hypotension, tachycardia, hypoxia) and plaque rupture (less common but important)
  • Recognition: may be silent under anaesthesia; ECG changes, haemodynamic instability, new arrhythmia, rising troponin post-op, pulmonary oedema
  • Immediate management: ABCs, treat hypoxia, correct hypotension (fluids/vasopressors), control heart rate, treat pain, correct anaemia; consider GTN if hypertensive/ischaemic; early cardiology/ICU involvement
  • Ongoing: postoperative ECG/troponin surveillance in high-risk patients per local pathways; optimise secondary prevention (statin, antiplatelet, beta-blocker if appropriate)

0 comments